SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-038953
Filing Date
2023-11-14
Accepted
2023-11-14 16:24:31
Documents
46
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q blcm-20230930.htm   iXBRL 10-Q 970547
2 EX-10.1 ex101amendmenttoconsulting.htm EX-10.1 11752
3 EX-31.1 a2023q3exhibit311.htm EX-31.1 11702
4 EX-32.1 a2023q3exhibit321.htm EX-32.1 5471
  Complete submission text file 0001628280-23-038953.txt   4065545

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20230930.xsd EX-101.SCH 31912
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20230930_cal.xml EX-101.CAL 35494
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20230930_def.xml EX-101.DEF 160597
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20230930_lab.xml EX-101.LAB 368820
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20230930_pre.xml EX-101.PRE 239997
40 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20230930_htm.xml XML 396426
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 231406800
SIC: 2834 Pharmaceutical Preparations